جست‌وجوی استاد و پژوهشگر

Larissa Schlegel-Papeمشاهده پروفایل

پژوهشگر

• Poultry Science
• Animal Welfare
• Stress Assessment in Chickens
• +۴ مورد دیگر

Larissa Schlegel-Pape serves as a Scientific Associate at the Department for Ornamental and Pedigree Poultry within the Farm Animal Clinic of Freie Universität Berlin's Faculty of Veterinary Medicine. Her work focuses on developing innovative methods for assessing chicken welfare through the creation of the "Stressed Chicken Scale," which aims to systematically identify stress indicators in poultry. Her research interests center on animal welfare science, specifically stress assessment in chickens using both behavioral observation and computer vision technology. She investigates how body posture, movement patterns, and other visual indicators can reliably signal discomfort or stress in poultry, with the goal of creating practical assessment tools for veterinarians and poultry farmers. Her work bridges veterinary medicine, ethology, and technological innovation, contributing to refinement research (one of the 3Rs principles) in animal husbandry. Analysis of her publications reveals a strong focus on developing and validating the Stressed Chicken Scale across multiple contexts. Her work spans methodological development, practical implementation studies, and technological integration with computer vision systems. The research demonstrates progression from conceptual framework to validation studies and practical application, with increasing sophistication in assessment techniques and broader implications for animal welfare standards in poultry farming. Schlegel-Pape actively collaborates with the Federal Institute for Risk Assessment (BfR) and participates in interdisciplinary projects involving artificial intelligence applications in agriculture. She presents her findings regularly at major German veterinary conferences including the DVG (Deutsche Veterinärmedizinische Gesellschaft) events, DACh Epidemiology conferences, and specialized poultry medicine gatherings. Her work contributes significantly to advancing animal welfare assessment methodologies and promoting refinement in poultry husbandry practices.

• Clinical Psychology
• Psychotherapy Process and Outcome
• Therapeutic Alliance
• +۷ مورد دیگر

Lauren M. Lipner, Ph.D., is an Assistant Professor in the Clinical Psychology Doctoral Program at Long Island University (LIU) Post, within the College of Liberal Arts and Sciences. She holds a B.A. from Pennsylvania State University and earned her M.A. and Ph.D. in Clinical Psychology from Adelphi University in 2020. Her academic and clinical training includes an APA-accredited pre-doctoral internship at Pennsylvania Hospital/University of Pennsylvania Health System, a clinical postdoctoral fellowship at Mount Sinai Beth Israel, and a research and teaching postdoctoral fellowship at Adelphi University. Her research focuses on psychotherapy process and outcome, with an emphasis on the development and repair of the therapeutic alliance. Key areas include alliance rupture resolution, factors contributing to premature treatment termination, and methodological approaches to measuring therapeutic dynamics. She has contributed extensively to the literature through peer-reviewed journal articles, book chapters, and conference presentations. The most recent publications reflect a strong trend in advancing methodological rigor in studying alliance ruptures, utilizing control chart methods, single-case designs, and multi-method approaches. Her work bridges clinical practice with empirical research, particularly in cognitive-behavioral and integrative therapies for personality and anxiety disorders. Scientific awards and grants highlight her recognition in the field: Small Research Grant, Society for Psychotherapy Research (2021) Charles J. Gelso, Ph.D. Psychotherapy Research Grant, Society for the Advancement of Psychotherapy (APA Division 29, 2023) Dr. Lipner has served as Principal Investigator on funded projects including 'The relationship between therapist flexibility, alliance rupture resolution, and premature treatment termination' and 'Reasons for dropout measure: Development and validation.' She is actively involved in professional organizations such as the American Psychological Association (Divisions 12 and 29), the Society for Psychotherapy Research, and the Society for the Exploration of Psychotherapy Integration. She regularly presents her research at national and international conferences, contributing to training and supervision literature, particularly in CBT and alliance-focused models. While no specific lab or research team is explicitly named in the text, her collaborative work with prominent researchers like Jeremy D. Safran, J. Christopher Muran, and Jacqueline P. Barber suggests active participation in a research network focused on psychotherapy process and integration. Her contributions to handbooks and case studies further indicate a strong commitment to clinical education and training.

Marc Schneiderمشاهده پروفایل

استاد

• Colloidal drug delivery systems
• Nanoparticle and microparticle engineering
• Nanotechnology in pharmacy
• +۳ مورد دیگر

Prof. Dr. Marc Schneider holds a professorship in Biopharmaceutics and Pharmaceutical Technology at Saarland University's College of Pharmacy . His research focuses on colloidal drug delivery systems, particularly nanostructured and non-spherical particle engineering for overcoming biological barriers in pulmonary and transdermal applications. He leads an internationally recognized lab in Saarbrücken, collaborating with Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and trinational institutions. Research Highlights: Development of inhalable nano/microparticle systems Surface modification of gelatin nanoparticles Characterization of mucus-penetrating particles 3D printing for microneedle fabrication Atomic Force Microscopy (AFM) for nanoparticle analysis Selected Scientific Awards: European Journal of Pharmaceutics and Biopharmaceutics Best Paper Award (2018) for mucus-penetrating nanoparticles Recognized in 'Ausgezeichnete Orte im Land der Ideen' competition (2018) for 'Nano-Mais' drug delivery system Collaborative Networks: Co-editor for Advanced Drug Delivery Reviews special issue on biological barriers Key participant in trinational Master's program in Biomedicine with Strasbourg, Mainz, and Luxembourg Active in Controlled Release Society (CRS) conferences and local chapters

Yeonhwa Parkمشاهده پروفایل

استاد

• Functional Foods
• Obesity
• Environmental Contaminants
• +۳ مورد دیگر

Yeonhwa Park is a Professor and holder of the Francis Chair in the Department of Food Science at the University of Massachusetts Amherst. Her research focuses on functional foods, bioactive components, and environmental contaminants' effects on obesity and aging. She investigates food bioactives like conjugated linoleic acid (CLA) and environmental pollutants like PFAS to understand their roles in metabolic disorders and aging mechanisms. Her work spans multiple models, including C. elegans, zebrafish, and rodent studies, emphasizing translational applications for human health. Teaching responsibilities include courses such as 'Science of Food' (FS150), 'Biology of Food in Human Health' (FS270), and 'Bioactive Food Components' (FS750). Awards include Clarivate Highly Cited Researcher (2017–2018), Faculty Convocation Award (2015), and the Timothy Mounts Award (2015). Her research has been published in over 150 peer-reviewed articles, with recent emphasis on environmental contaminants' impact on obesity and type 2 diabetes, and the use of C. elegans for screening bioactives. Key findings include CLA's role in fat reduction, PFAS-induced metabolic disruption, and the application of alternative models (e.g., C. elegans) to reduce animal testing. Her lab integrates molecular biology, toxicology, and food science to address global health challenges like the obesity epidemic and environmental toxin exposure.

• Animal Behaviour
• Animal Welfare
• Comparative Color Vision
• +۳ مورد دیگر

Professor Hannah Buchanan-Smith is a Professor of Psychology at the University of Stirling, Faculty of Natural Sciences. She holds multiple external roles including Member of the UK Zoos Expert Committee advising DEFRA and devolved governments, Leader of the 'Welfare and mixed-species living' project at the Living Links Executive Board, and Corresponding member of the Primate Society of Great Britain's Captive Care Working Party. Her research focuses on animal behavior, welfare, and ecology with a particular emphasis on non-human primates. Education: PhD from University of Reading, postdoctoral work at St Andrews University Research interests include comparative color vision evolution, refinement of laboratory animal care (3Rs principles), and welfare assessment in zoos. She promotes welfare through open-access resources like the Marmoset Care website and the NC3Rs Macaque Website. Collaborations include RZSS Edinburgh Zoo and Blair Drummond Safari Park. Recent articles explore cultural differences in zoo visitor attitudes, social dynamics in mixed-species exhibits, and welfare implications of circadian rhythms in captive pandas. Her work bridges theoretical research with applied welfare practices, emphasizing translational science between field observations and captive environments. Awards: Extensive professional recognitions through committee memberships but no specific named awards listed Advising: Supervised Dr. Lou Tasker (PhD) and others through BBSRC CASE studentships. Active in grant-funded projects including EU, BBSRC, and NC3Rs initiatives. Leads the 24/7 welfare approach framework for captive animals. Labs/Teams: Core member of Scottish Primate Research Group, affiliated with the Behaviour and Evolution Research Group at Stirling. Collaborates internationally through IUCN Species Survival Commission.

Hermann Cuntzمشاهده پروفایل

پژوهشگر

• Neuroscience
• Computational Neuroscience
• Neuroinformatics
• +۴ مورد دیگر

Dr. Hermann Cuntz is an Independent Group Leader at the Ernst Strüngmann Institute (ESI) for Neuroscience in cooperation with the Max Planck Society. He is also a Research Fellow at the Frankfurt Institute for Advanced Studies (FIAS) since 2014 and affiliated with the Goethe University Frankfurt via the Institute of Clinical Neuroanatomy . His email address is hermann.neuro@gmail.com , and he is based in Frankfurt am Main, Germany. Research Focus: Dr. Cuntz investigates principles of neuronal wiring, aiming to decode the "connection code" of the brain. His work bridges morphology and function using computational tools, mathematical laws, and morphological modeling. Key areas include dendritic constancy , structural plasticity , connectomics , and neuroinformatics , with applications in understanding neurodegenerative diseases like Alzheimer’s. Education: PhD from the University of California at Berkeley and Max Planck Institute of Neurobiology (2000-2004). Diploma in biology from Eberhard Karls Universität Tübingen (1994-2000). Recent Publications highlight research trends in dendritic structure, pattern separation, synaptic spine distribution, and cortical folding. His lab develops the TREES Toolbox , a MATLAB-based framework for neuronal morphology analysis. Scientific Awards: Bernstein Award (2013-2019) DFG Eigene Stelle (2014-2016) Feodor Lynen Fellowship (Alexander von Humboldt, 2006-2008) Minerva Fellowship (2004-2005) Wellcome Image Award (2011) 1st Prize Poster Competition, UCL Neuroscience Symposium (2010) Advising and Grants: Dr. Cuntz mentors numerous PhD and Master’s students, including Marcel Beining , Mariuss Schneider , and Marvin Weigand . His lab receives funding from the DFG , Bernstein Award , and collaborations with institutions like the 3R-Center Giessen and Interdisciplinary Centre for 3Rs (ICAR3R) . Labs and Collaborations: The Cuntz Lab specializes in computational neuroanatomy, with alumni working globally in academia and industry. Key collaborators include Prof. Peter Jedlicka (Justus Liebig University), Prof. Gaia Tavosanis (DZNE Bonn), and Prof. Alexander Borst (MPI Neurobiology).

Linda Kockمشاهده پروفایل

استادیار

• Biomechanics
• Tissue Engineering
• Orthopaedics
• +۴ مورد دیگر

Linda Kock is an Assistant Professor (Part-time) in the Department of Biomedical Engineering at Eindhoven University of Technology, specializing in the Orthopaedic Biomechanics research group. Her work focuses on developing ex vivo models for studying bone dynamics, liver function, and tissue engineering applications. Dr. Kock's research primarily centers on biomechanics and tissue engineering, with particular emphasis on: Ex vivo culture systems for bone and cartilage tissue Liver perfusion and transplantation models Organoid development and application in regenerative medicine Longitudinal monitoring of tissue dynamics using advanced imaging techniques Development of alternatives to animal experimentation in medical research Her recent publications demonstrate a strong focus on creating clinically relevant ex vivo models that bridge the gap between laboratory research and clinical applications, particularly in orthopaedics and liver transplantation. She has developed innovative approaches for monitoring bone remodeling through micro-CT scanning and has investigated the use of slaughterhouse-obtained livers as alternatives to laboratory pigs for perfusion research. Dr. Kock has received research funding from several prestigious sources including the European Union's Horizon 2020 research program under Marie Sklodowska-Curie grant agreements and the Netherlands Organization for Scientific Research through the ERC Proof of Concept program and Gravitation Program. She is actively contributing to the advancement of regenerative medicine techniques that align with the 3Rs principle (Replacement, Reduction, Refinement) in medical research, providing valuable platforms for testing drug treatments and evaluating implant performance under controlled conditions that better reflect human physiology.

Xiao-Hua Qinمشاهده پروفایل

استادیار

• Biomaterials Engineering
• Regenerative Medicine
• Tissue Engineering
• +۵ مورد دیگر

Prof. Xiao-Hua Qin is an Assistant Professor in the Department of Health Sciences and Technology at ETH Zürich, leading the Biomaterials Engineering research team and co-leading the Laboratory for Bone Biomechanics. He specializes in creating biomaterials for tissue biomanufacturing and regenerative medicine, with a focus on miniaturized in vitro bone models for disease modeling and drug discovery. His work has been recognized by prestigious grants such as the ERC Starting Grant and SNSF NRP 79, and he co-leads editorial roles for Biomedical Materials . He teaches courses on engineering with living materials and multiscale bone biomechanics. His research emphasizes constructing 3D microenvironments to study bone physiology/pathology, with recent breakthroughs in hydrogel-based systems for cell network formation and organoid-on-chip tools. He has pioneered techniques like two-photon subtractive biofabrication and volumetric bioprinting. Qin's honors include Young Academy of Europe membership and multiple awards for innovative biomaterials and poster presentations. He mentors 6 PhD students and collaborates across disciplines, aiming to replace animal experiments with human organoid models (3Rs principle). His lab's innovations span biodegradable hydrogels, photoresponsive materials, and microscale 3D printing technologies.

Ben Lecorpsمشاهده پروفایل

مدرس ارشد

• Animal welfare
• Animal emotions
• Animal cognition
• +۴ مورد دیگر

Dr. Ben Lecorps serves as a Senior Lecturer at the Bristol Veterinary School, University of Bristol, specializing in animal welfare science with a focus on emotional states and cognitive processes in farm animals. His expertise directly addresses welfare assessment in dairy systems and laboratory settings through innovative methodological approaches. Dr. Lecorps holds a PhD, MSc, and BSc in relevant disciplines, forming the foundation for his research in animal sentience. His educational trajectory supports his interdisciplinary approach combining veterinary science, behavioral biology, and ethics. His research program centers on Animal Welfare , Animal Emotions , and Animal Cognition , with particular emphasis on dairy cattle , pain assessment , and affective state measurement . He pioneers cognitive bias testing (e.g., judgment bias paradigms) and physiological monitoring to quantify emotions like pessimism and anhedonia in calves and heifers. Current investigations span disbudding pain management, hunger effects on cognition, and human-animal relationship impacts, bridging fundamental neuroscience with practical on-farm applications. Analysis of his 15 most recent publications (2021-2025) reveals three dominant research strands: (1) development of welfare assessment tools (conditioned place preference/aversion tests), (2) dairy-specific welfare challenges (disbudding, regrouping, transportation), and (3) policy implications of welfare science (EU regulations, organic standards). His work consistently integrates behavioral, cognitive, and physiological metrics to advance evidence-based welfare frameworks. Dr. Lecorps actively supervises student research projects and theses within the Bristol Veterinary School. While specific grant details aren't public, his output suggests sustained funding for experimental welfare studies involving dairy cattle, pigs, and poultry systems. His collaborative network includes key figures like Professor Michael Mendl (Animal Behaviour and Welfare) and Dr. Suzanne Held (Behavioural Biology), forming a cohesive research group focused on affective neuroscience in farm animals. The Langford-based research team employs advanced methodologies including non-linear heart rate variability analysis, cognitive testing arenas, and behavioral observation protocols. Current projects investigate pain-emotion interactions in calves, social learning in poultry, and regulatory effectiveness for transport welfare, positioning the group at the forefront of translational animal welfare science.

Philip Taylorمشاهده پروفایل

استاد

• Immunology
• Macrophage biology
• Innate immune system
• +۵ مورد دیگر

Professor Philip Taylor is a Professor of Translational Immunology in the Division of Infection and Immunity at Cardiff University's School of Medicine. He serves as PGR Lead for the Systems Immunity Research Institute and is a UK Dementia Research Institute Professor. His research focuses on the innate immune system, particularly macrophages, myeloid cell surface receptors, and the complement system. His educational background includes a PhD in Molecular Genetics from Imperial College London (1998) and a BSc in Human Genetics from University College London (1994). His career progression shows a strong trajectory in immunology research, with positions at Oxford University before joining Cardiff University. Professor Taylor's research interests center on macrophage biology, particularly their origins, development, renewal, and transcriptional control of cellular activation. More recently, he has developed a significant focus on microglia in dementia, especially Alzheimer's disease. He also has interests in developing technologies that promote the 3Rs (Replacement, Reduction, Refinement) in animal research while maintaining scientific excellence. His work heavily involves experimental murine models of disease and immunity with the ultimate goal of elucidating novel mechanisms to manipulate macrophage activity for beneficial outcomes in disease. His recent publications demonstrate a strong trend toward understanding the role of the immune system in neurodegenerative diseases, particularly Alzheimer's, while maintaining his foundational work on macrophage biology and pathogen recognition. The research spans multiple disciplines including immunology, neuroscience, cell biology, and genetics, with strong translational potential. Recipient of a Wellcome Trust Investigator Award (2016-2021) Recipient of a Medical Research Council Senior Fellowship (2007-2014) Awarded Research Lecturer status, Oxford University (2006) Recipient of a Wellcome Trust Research Career Development Fellowship (2003-2007) Awarded RSII status, Oxford University (2002) Recipient of Medical Research Council PhD studentship (1994) Professor Taylor leads the Myeloid Cell Biology Group at Cardiff University, which investigates macrophage biology in homeostasis and disease, as well as the role of microglia in dementia. His current grant funding includes an MRC UK Dementia Research Institute Programme Grant (2017-2023) worth £1.7M and a Wellcome Trust Investigator Award (2016-2021) worth £1.41M. His research group is actively involved in understanding how genes implicated in Alzheimer's disease impact microglial function, with the aim of inspiring novel therapeutic approaches. The Myeloid Cell Biology Group is investigating professional phagocytes (macrophages, dendritic cells, and neutrophils) and their diverse roles in development, host defense, inflammation, wound healing, and immune surveillance. The group focuses on fundamental aspects of phagocyte biology, including pathogen recognition receptors, downstream signaling, and cellular activation events, with the goal of manipulating cell behavior for therapeutic benefit.

Rachel Tannerمشاهده پروفایل

دانشیار

• Tuberculosis vaccine research
• Immune correlates of protection
• Humoral immune response
• +۵ مورد دیگر

Rachel Tanner is an Associate Professor and Lecturer in Human Sciences at Wadham College, University of Oxford, with additional appointments as Research Fellow at Wolfson College and Access Officer for the Institute of Human Sciences. Her research focuses on tuberculosis vaccine development through analysis of immune correlates, particularly the humoral response to BCG vaccination and development of functional in vitro assays. Education MA in Biological Sciences, University of Oxford DPhil in Clinical Medicine, University of Oxford Her work addresses critical gaps in TB vaccine development by: Identifying humoral immune correlates of protection Developing in vitro mycobacterial growth inhibition assays (MGIA) to reduce animal use Investigating controlled human infection models Exploring non-specific effects of BCG vaccination Advancing bovine TB vaccine research She leads initiatives aligning with the 3Rs principles for animal research. Notable scientific awards include: TBVI Young Scientist Award (2017) CTVD Early Career Scientist Award (2018) 'Women of the Future' Award for Science (2019) Current research projects involve: Comparative analysis of BCG and MTBVAC vaccines Route-specific antibody functionality Development of novel TB vaccine candidates Standardisation of functional immune assays She contributes to scientific governance through roles on: British Society for Immunology Vaccine Affinity Group Acid Fast Club committee Oxford University Animal Care and Ethical Review 3Rs subcommittee Scientific Reports Editorial Board

Matthias Eggelمشاهده پروفایل

پژوهشگر ارشد

• Animal Research Ethics
• Bioethics
• Gene Editing Ethics
• +۵ مورد دیگر

Dr. Matthias Eggel is a Post-Doctoral Fellow at the Department of Philosophy, Faculty of Humanities, University of Basel. He holds dual PhDs in Molecular Biology & Biochemistry (University of Bern, 2015) and Animal Ethics (University of Zurich/Vienna, 2018) and specializes in ethics of animal research, gene editing, and biomedical ethics. Education: Master's in Human Physiology (University of Zurich, 2010), PhD in Molecular Biology (University of Bern, 2015), PhD in Animal Ethics (University of Zurich/Vienna, 2018) His research focuses on Animal Research Ethics and Gene Editing Ethics , with particular emphasis on harm-benefit analysis, the 3Rs principle, genetic disenhancement, and regulatory frameworks for animal experimentation. Recent work compares European regulations for animal research authorization and critiques ethical justification models. Dr. Eggel serves on Switzerland's National Ethics Committee in Animal Experimentation (SAMW) and the Cantonal Animal Research Review Committee in Fribourg. He teaches Animal Ethics courses to Life Science, Veterinary, Medical, and transdisciplinary students. Key collaborations: University of Zurich, Messerli Research Institute (Vienna), University of Bern Notable methodologies: Comparative ethics analysis, regulatory policy evaluation

• Regulatory Toxicology
• Occupational Toxicology
• Food Safety
• +۴ مورد دیگر

Leon H. Bruner is an Adjunct Professor at Michigan State University's Institute for Integrative Toxicology, specializing in regulatory and occupational food toxicology. He combines three decades of industry experience with academic roles. Education: B.S., DVM, and Ph.D. in Pharmacology from Michigan State University; Postdoctoral Fellow at University of Michigan His research focuses on developing and validating alternatives to animal testing , particularly the Draize eye irritation test , emphasizing in vitro toxicity assessment , product safety , and regulatory compliance . Key areas include ocular irritancy models , silicon microphysiometer applications , and international validation studies . Key trends in publications (1983-2002) span ocular safety , in vitro methodology , and regulatory toxicology , with collaborations across institutions like COLIPA, EC/HO, and ECVAM. His work bridges industrial standards with academic research. He has contributed to international validation frameworks and toxicity testing guidelines , though no specific awards are listed. Current roles involve applied consumer product safety research and education policy at the Institute for Integrative Toxicology.

Robin Williamsمشاهده پروفایل

استاد

• Molecular Cell Biology
• Neuroscience
• Pharmacology
• +۸ مورد دیگر

Robin Williams is a Professor of Molecular Cell Biology at the Department of Biological Sciences and Head of the Centre for Biomedical Sciences at Royal Holloway University of London. His research focuses on molecular cell biology, neuroscience, and pharmacology, using the social amoeba Dictyostelium as a model system to study epilepsy, Alzheimer’s, bipolar disorder, and drug development. He has pioneered 3Rs initiatives (Replace, Reduce, Refine) to reduce animal testing in research. Education: PhD in Molecular Cell Biology (University of Melbourne, 1994), postdoctoral training at St Andrews University and UCL. Joined Royal Holloway in 2006. Research Interests: Epilepsy treatments, Alzheimer’s disease mechanisms, bipolar disorder pharmacology, natural product therapeutics, bitter taste mechanisms, and translational drug discovery. His work emphasizes developing safer treatments and advancing non-animal research models. Key Collaborations: Prof Matthew Walker (epilepsy research), Prof Alan Kimmel (protein conservation studies), GlaxoSmithKline (bitter taste research). Industry partnerships include Vitaflo Ltd (ketogenic therapies). Recent Articles: Focus on medium-chain fatty acids’ roles in energy metabolism, cannabinoid mechanisms, and Dictyostelium-based drug discovery. Highlights include identifying the molecular basis of the ketogenic diet and novel treatments for drug-resistant epilepsy. Awards & Esteem: Member of Global Executive Board for the International Neurological Ketogenic Society, advisor to epilepsy charities, and organizer of international conferences. Recognized for contributions to 3Rs and translational research. Grants & Funding: Multiple BBSRC and MRC grants for epilepsy and metabolic research. Leads projects on safer epilepsy drugs and cannabinoid mechanisms. Labs/Teams: Active in the Centre for Biomedical Sciences, collaborating across disciplines to bridge basic science and clinical applications.

Adeyemi Adedejiمشاهده پروفایل

پژوهشگر

• Clinical Pathology
• Toxicology
• Translational Biomarkers
• +۶ مورد دیگر

Adeyemi Adedeji serves as Distinguished Scientist-Pathologist and Head of Clinical Pathology in Translational Safety Pathology within Development Sciences at Genentech, where he has contributed for nine years to oncology and non-oncology therapeutic safety assessment. His expertise bridges clinical pathology, translational biomarker development, and immunotoxicology to support preclinical safety evaluation of biologics and small molecules. His educational background includes: Doctor of Veterinary Medicine (DVM) from University of Ibadan, Nigeria (2005) PhD in Molecular Microbiology from University of Missouri-Columbia (2012) Veterinary Clinical Pathology Residency at University of California-Davis (2015) Diplomate of American College of Veterinary Pathologists (2015) Dr. Adedeji's research focuses on advancing clinical pathology endpoints for drug safety assessment, with particular emphasis on urinary biomarker development, immunotoxicology, and implementation of 3Rs principles (Replacement, Reduction, Refinement) in toxicity studies. His work has established novel approaches for urinary biomarker normalization, microsampling techniques, and fasting protocol optimization to enhance animal welfare without compromising data quality. As Project Pathologist, he integrates clinical pathology data with anatomic findings to assess pharmacological and toxicological effects, directly contributing to regulatory submissions. His 33 Genentech publications demonstrate consistent focus on translational biomarker qualification, with recent work emphasizing deep learning applications in bone marrow analysis, bispecific antibody safety assessment, and cardiovascular toxicity mechanisms of TGFβ inhibitors. The research shows increasing sophistication in integrating multiple data streams for comprehensive safety assessment. His scientific recognition includes: 3Rs Genentech 1st place Award (2024) Society of Toxicology Best Paper Award (2023) 3Rs Global Roche 1st place award (2023) American College of Toxicology Best Paper Award (2020) Multiple Genentech Creative Genius Awards (2017-2018) As Project Pathologist, Dr. Adedeji provides scientific leadership across multiple therapeutic programs, collaborating with global pathologists and scientists to design preclinical safety studies and interpret findings for regulatory submissions. He actively contributes to establishing scientific standards through participation in the Scientific and Regulatory Policy Committee, focusing on integration of clinical and anatomic pathology data. His work with the 3Rs Advisory Group has led to significant refinements in toxicity study protocols, enhancing animal welfare while maintaining scientific rigor. Dr. Adedeji leads the Safety Biomarker Expert Resources team, driving scientific and technical support for identification, development, and validation of translational biomarkers. His group collaborates with global biomarker and immunotoxicology teams to advance technologies supporting safety studies and in-vivo safety models.